|
2025-03-25 |
2025-03-24 |
VP
Vente planifiée
|
Sacco Tracey
Chief Commercial Officer
Dirigeant
|
5 000
-6.5%
32,89
164 459 USD
|
5 000
-6.5%
|
32,89
|
164 459 USD
|
|
|
2025-03-25 |
2025-03-24 |
VP
Vente planifiée
|
Sacco Tracey
Chief Commercial Officer
Dirigeant
|
1 500
-1.9%
33,70
50 556 USD
|
1 500
-1.9%
|
33,70
|
50 556 USD
|
|
|
2025-03-25 |
2025-03-24 |
VP
Vente planifiée
|
Moore Erin
Interim PFO and PAO
Dirigeant
|
13 564
-14.1%
33,12
449 237 USD
|
13 564
-14.1%
|
33,12
|
449 237 USD
|
|
|
2025-03-19 |
2025-03-17 |
VP
Vente planifiée
|
Peng Katie
Administrateur non-exécutif
|
1 006
-3.2%
34,42
34 627 USD
|
1 006
-3.2%
|
34,42
|
34 627 USD
|
|
|
2025-03-12 |
2025-03-10 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
29 395
-20.9%
34,87
1 025 004 USD
|
29 395
-20.9%
|
34,87
|
1 025 004 USD
|
|
|
2025-03-12 |
2025-03-10 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
112 897
-44.5%
35,82
4 043 971 USD
|
112 897
-44.5%
|
35,82
|
4 043 971 USD
|
|
|
2025-02-20 |
2025-02-19 |
VP
Vente planifiée
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
20 202
-15.4%
37,74
762 498 USD
|
20 202
-15.4%
|
37,74
|
762 498 USD
|
|
|
2025-02-20 |
2025-02-19 |
VP
Vente planifiée
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
8 341
-6.0%
37,56
313 289 USD
|
8 341
-6.0%
|
37,56
|
313 289 USD
|
|
|
2025-02-20 |
2025-02-19 |
VP
Vente planifiée
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
39 967
-22.3%
37,20
1 486 692 USD
|
39 967
-22.3%
|
37,20
|
1 486 692 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Vente
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
4 135
-3.1%
36,83
152 288 USD
|
4 135
-3.1%
|
36,83
|
152 288 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
5 296
-3.6%
36,83
195 046 USD
|
5 296
-3.6%
|
36,83
|
195 046 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Vente
|
Myles Edward H
COO & CFO
Dirigeant
|
7 809
-5.3%
36,83
287 598 USD
|
7 809
-5.3%
|
36,83
|
287 598 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Vente
|
Ho Junlin
GENERAL COUNSEL
Dirigeant
|
5 742
-2.9%
36,83
211 472 USD
|
5 742
-2.9%
|
36,83
|
211 472 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Vente
|
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
18 372
-5.6%
36,83
676 622 USD
|
18 372
-5.6%
|
36,83
|
676 622 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Ho Junlin
GENERAL COUNSEL
Dirigeant
|
9 039
-4.4%
44,20
399 498 USD
|
9 039
-4.4%
|
44,20
|
399 498 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
7 347
-5.1%
44,20
324 717 USD
|
7 347
-5.1%
|
44,20
|
324 717 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Myles Edward H
COO & CFO
Dirigeant
|
12 539
-7.8%
44,20
554 189 USD
|
12 539
-7.8%
|
44,20
|
554 189 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Sacco Tracey
Chief Commercial Officer
Dirigeant
|
3 890
-7.9%
44,20
171 927 USD
|
3 890
-7.9%
|
44,20
|
171 927 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
6 434
-4.2%
44,20
284 365 USD
|
6 434
-4.2%
|
44,20
|
284 365 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
5 655
-7.8%
44,20
249 935 USD
|
5 655
-7.8%
|
44,20
|
249 935 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Vente
|
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
22 308
-6.3%
44,20
985 951 USD
|
22 308
-6.3%
|
44,20
|
985 951 USD
|
|
|
2024-12-12 |
2024-12-10 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
1 600 000
-14.7%
41,65
66 640 000 USD
|
1 600 000
-14.7%
|
41,65
|
66 640 000 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
149
-0.0%
40,98
6 106 USD
|
149
-0.0%
|
40,98
|
6 106 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
30 683
-0.3%
40,14
1 231 585 USD
|
30 683
-0.3%
|
40,14
|
1 231 585 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
126 442
-1.1%
39,51
4 995 774 USD
|
126 442
-1.1%
|
39,51
|
4 995 774 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
43 887
-0.4%
38,43
1 686 670 USD
|
43 887
-0.4%
|
38,43
|
1 686 670 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
208 272
-1.8%
37,63
7 837 504 USD
|
208 272
-1.8%
|
37,63
|
7 837 504 USD
|
|
|
2024-11-26 |
2024-11-25 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
200
-0.3%
40,72
8 144 USD
|
200
-0.3%
|
40,72
|
8 144 USD
|
|
|
2024-11-26 |
2024-11-25 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
3 075
-4.0%
39,93
122 780 USD
|
3 075
-4.0%
|
39,93
|
122 780 USD
|
|
|
2024-11-26 |
2024-11-25 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
2 100
-2.7%
39,25
82 434 USD
|
2 100
-2.7%
|
39,25
|
82 434 USD
|
|
|
2024-11-26 |
2024-11-25 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
1 000
-1.3%
38,04
38 041 USD
|
1 000
-1.3%
|
38,04
|
38 041 USD
|
|
|
2024-11-26 |
2024-11-22 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
2 145
-2.9%
30,01
64 372 USD
|
2 145
-2.9%
|
30,01
|
64 372 USD
|
|
|
2024-11-13 |
2024-11-11 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
2 105
-2.8%
30,00
63 158 USD
|
2 105
-2.8%
|
30,00
|
63 158 USD
|
|
|
2024-10-10 |
2024-10-08 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
37 187
-18.8%
34,90
1 297 659 USD
|
37 187
-18.8%
|
34,90
|
1 297 659 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
39 375
-35.1%
30,06
1 183 652 USD
|
39 375
-35.1%
|
30,06
|
1 183 652 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
2 552
-2.2%
26,22
66 923 USD
|
2 552
-2.2%
|
26,22
|
66 923 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Dirigeant
|
67 448
-37.0%
25,59
1 725 893 USD
|
67 448
-37.0%
|
25,59
|
1 725 893 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Sacco Tracey
CHIEF COMMERCIAL OFFICER
Dirigeant
|
1 964
-3.8%
26,23
51 516 USD
|
1 964
-3.8%
|
26,23
|
51 516 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Sacco Tracey
CHIEF COMMERCIAL OFFICER
Dirigeant
|
28 036
-35.4%
25,58
717 161 USD
|
28 036
-35.4%
|
25,58
|
717 161 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
31 250
-16.2%
29,05
907 813 USD
|
31 250
-16.2%
|
29,05
|
907 813 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
25 812
-11.8%
27,27
703 893 USD
|
25 812
-11.8%
|
27,27
|
703 893 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
37 206
-14.6%
26,83
998 237 USD
|
37 206
-14.6%
|
26,83
|
998 237 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
111 972
-30.5%
25,61
2 867 603 USD
|
111 972
-30.5%
|
25,61
|
2 867 603 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
|
155 713
-2.7%
32,50
5 060 673 USD
|
155 713
-2.7%
|
32,50
|
5 060 673 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
|
510 000
-8.1%
30,00
15 300 000 USD
|
510 000
-8.1%
|
30,00
|
15 300 000 USD
|
|
|
2024-10-07 |
2024-10-07 |
VP
Vente planifiée
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
|
510 000
-7.5%
27,50
14 025 000 USD
|
510 000
-7.5%
|
27,50
|
14 025 000 USD
|
|
|
2024-09-19 |
2024-09-16 |
V
Vente
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
1 936
-1.3%
8,58
16 611 USD
|
1 936
-1.3%
|
8,58
|
16 611 USD
|
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
1 451
-0.9%
9,33
13 538 USD
|
1 451
-0.9%
|
9,33
|
13 538 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Vente
|
Myles Edward H
COO & CFO
Dirigeant
|
9 458
-4.5%
8,98
84 978 USD
|
9 458
-4.5%
|
8,98
|
84 978 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Vente
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
2 315
-1.6%
8,99
20 800 USD
|
2 315
-1.6%
|
8,99
|
20 800 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
4 305
-2.7%
8,98
38 680 USD
|
4 305
-2.7%
|
8,98
|
38 680 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Vente
|
Ho Junlin
GENERAL COUNSEL
Dirigeant
|
4 695
-2.2%
8,98
42 183 USD
|
4 695
-2.2%
|
8,98
|
42 183 USD
|
|
|
2024-02-21 |
2024-02-16 |
V
Vente
|
Myles Edward H
COO & CFO
Dirigeant
|
4 744
-2.2%
15,74
74 686 USD
|
4 744
-2.2%
|
15,74
|
74 686 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
3 751
-2.3%
15,74
59 053 USD
|
3 751
-2.3%
|
15,74
|
59 053 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Ho Junlin
GENERAL COUNSEL
Dirigeant
|
3 489
-1.6%
15,74
54 928 USD
|
3 489
-1.6%
|
15,74
|
54 928 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
2 512
-1.7%
15,74
39 547 USD
|
2 512
-1.7%
|
15,74
|
39 547 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
11 614
-3.2%
15,74
182 842 USD
|
11 614
-3.2%
|
15,74
|
182 842 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Ho Junlin
GENERAL COUNSEL
Dirigeant
|
4 186
-2.6%
15,93
66 677 USD
|
4 186
-2.6%
|
15,93
|
66 677 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Qatanani Mo
SVP AND HEAD OF RESEARCH
Dirigeant
|
2 002
-2.5%
15,93
31 889 USD
|
2 002
-2.5%
|
15,93
|
31 889 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
2 849
-2.4%
15,93
45 381 USD
|
2 849
-2.4%
|
15,93
|
45 381 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Myles Edward H
COO & CFO
Dirigeant
|
6 634
-3.9%
15,93
105 670 USD
|
6 634
-3.9%
|
15,93
|
105 670 USD
|
|
|
2023-12-29 |
2023-12-29 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
300
-0.2%
19,51
5 853 USD
|
300
-0.2%
|
19,51
|
5 853 USD
|
|
|
2023-12-29 |
2023-12-29 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
12 159
-6.7%
18,82
228 780 USD
|
12 159
-6.7%
|
18,82
|
228 780 USD
|
|
|
2023-12-15 |
2023-12-14 |
V
Vente
|
Qatanani Mo
SVP AND HEAD OF RESEARCH
Dirigeant
|
24 662
-23.4%
18,18
448 444 USD
|
24 662
-23.4%
|
18,18
|
448 444 USD
|
|
|
2023-12-08 |
2023-12-07 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
24 914
-12.9%
17,53
436 820 USD
|
24 914
-12.9%
|
17,53
|
436 820 USD
|
|
|
2023-11-03 |
2023-11-02 |
VP
Vente planifiée
|
Myles Edward H
COO & CFO
Dirigeant
|
35 007
-17.2%
12,51
438 039 USD
|
35 007
-17.2%
|
12,51
|
438 039 USD
|
|
|
2023-10-18 |
2023-10-16 |
A
Achat
|
Samsara BioCapital GP, LLC
Actionnaire important
|
2 189 781
+47.6%
6,85
15 000 000 USD
|
2 189 781
+47.6%
|
6,85
|
15 000 000 USD
|
|
|
2023-10-18 |
2023-10-16 |
A
Achat
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
Actionnaire important
|
2 189 781
+47.6%
6,85
15 000 000 USD
|
2 189 781
+47.6%
|
6,85
|
15 000 000 USD
|
|
|
2023-10-16 |
2023-10-12 |
A
Achat
|
Invus Public Equities, L.P.
Actionnaire important
|
10 150
+0.1%
8,55
86 736 USD
|
10 150
+0.1%
|
8,55
|
86 736 USD
|
|
|
2023-10-16 |
2023-10-12 |
A
Achat
|
Invus Public Equities, L.P.
Actionnaire important
|
2 189 781
+24.2%
6,85
15 000 000 USD
|
2 189 781
+24.2%
|
6,85
|
15 000 000 USD
|
|
|
2023-09-20 |
2023-09-18 |
V
Vente
|
Qatanani Mo
SVP AND HEAD OF RESEARCH
Dirigeant
|
1 945
-2.0%
6,34
12 331 USD
|
1 945
-2.0%
|
6,34
|
12 331 USD
|
|
|
2023-08-18 |
2023-08-16 |
V
Vente
|
Parlavecchio Caryn
CHRO
Dirigeant
|
1 353
-1.1%
6,83
9 241 USD
|
1 353
-1.1%
|
6,83
|
9 241 USD
|
|
|
2023-05-02 |
2023-04-28 |
A
Achat
|
Invus Public Equities, L.P.
Actionnaire important
|
31 557
+0.3%
6,43
202 845 USD
|
31 557
+0.3%
|
6,43
|
202 845 USD
|
|
|
2023-01-11 |
2023-01-09 |
V
Vente
|
Invus Public Equities, L.P.
Actionnaire important
|
1 094
-0.0%
9,48
10 373 USD
|
1 094
-0.0%
|
9,48
|
10 373 USD
|
|
|
2023-01-09 |
2023-01-05 |
A
Achat
|
Invus Public Equities, L.P.
Actionnaire important
|
48 774
+0.5%
9,33
455 091 USD
|
48 774
+0.5%
|
9,33
|
455 091 USD
|
|
